Linking the relationship between drug-induced osteoporosis and the gut microbiota
-
By
-
Monika Martiniakova
-
Anna Sarocka
-
Noemi Penzes
-
Vladimira Mondockova
-
Aneta Sevcikova
-
Sona Ciernikova
-
Veronika Kovacova
-
Roman Biro
-
Joanna Folwarczna
-
Radoslav Omelka
-
June 1, 2026
-
Clinical Scorecard: Exploring the Connection Between Osteoporosis Induced by Medications and Gut Microbiota Alterations
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Alterations in gut microbiota affecting bone health through immune modulation and nutrient absorption. |
| Target Population | |
| Care Setting | |
Key Highlights
- Drug-induced osteoporosis is a significant global health concern affecting over 200 million individuals.
- The gut microbiota plays a role in regulating bone homeostasis.
Guideline-Based Recommendations
Diagnosis
- Identify secondary causes of osteoporosis, including medication use.
Management
- Consider pharmacological interventions and lifestyle modifications.
Monitoring & Follow-up
- Preventive monitoring of bone mineral density (BMD) is essential.
Risks
- Chronic use of certain medications can lead to reduced BMD.
Patient & Prescribing Data
Patients using medications associated with secondary osteoporosis.
Therapeutic approaches include pharmacological interventions and lifestyle changes.
Clinical Best Practices
- Regular assessment of bone health in patients on long-term medication.
- Encourage adequate intake of calcium and vitamin D.
Related Resources & Content
